{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:55Z","timestamp":1791216055447,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jsbmb.2005.11.005","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T07:41:16Z","timestamp":1142408476000},"page":"19-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Changes in oestrogen receptor-\u03b1 and -\u03b2 during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells"],"prefix":"10.1016","volume":"99","author":[{"given":"L.E.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pugazhendhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Darbre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2005.11.005_bib1","first-page":"1","volume":"18","year":"2004","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0305-7372(02)00036-1","article-title":"Tamoxifen (\u2018Nolvadex\u2019): a review","volume":"28","author":"Clemons","year":"2002","journal-title":"Cancer Treatment Rev."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib3","first-page":"47","article-title":"The use of selective estrogen receptor modulators and selective estrogen down-regulators in breast cancer","author":"Howell","year":"2004","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1677\/erc.1.00776","article-title":"Mechanisms of tamoxifen resistance","volume":"11","author":"Ring","year":"2004","journal-title":"Endocrine-related Cancer"},{"issue":"Suppl. 12","key":"10.1016\/j.jsbmb.2005.11.005_bib5","first-page":"4369s","article-title":"Preliminary experience with pure antiestrogens","volume":"7","author":"Howell","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/14737140.2.2.151","article-title":"Fulvestrant (Faslodex): current status in the therapy of breast cancer","volume":"2","author":"Bundred","year":"2002","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib7","series-title":"Estrogen and Breast Cancer","author":"Miller","year":"1996"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib8","first-page":"4355","article-title":"Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens","volume":"47","author":"Katzenellenbogen","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/0277-5379(87)90062-9","article-title":"Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture","volume":"23","author":"Welshons","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib10","first-page":"5868","article-title":"Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells","volume":"50","author":"Daly","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib11","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","article-title":"Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells","volume":"139","author":"Jeng","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1054\/bjoc.2000.1388","article-title":"Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid","volume":"83","author":"Stephen","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib13","doi-asserted-by":"crossref","first-page":"40080","DOI":"10.1074\/jbc.M105892200","article-title":"Insulin-like growth factor receptor levels are regulated by cell density and by long-term estrogen deprivation in MCF7 human breast cancer cells","volume":"276","author":"Stephen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(02)00074-2","article-title":"Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation","volume":"81","author":"Chan","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0960-0760(03)00366-2","article-title":"Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways","volume":"86","author":"Yue","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0277-5379(89)90348-9","article-title":"Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture","volume":"25","author":"Murphy","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib17","first-page":"333","article-title":"Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D","volume":"50","author":"Mullick","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1210\/en.2002-220620","article-title":"Elevated levels of epidermal growth factor receptor\/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells","volume":"144","author":"Knowlden","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib19","first-page":"3229","article-title":"MCF7\/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780","volume":"53","author":"Brunner","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib20","first-page":"4130","article-title":"Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling","volume":"60","author":"Badia","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib21","first-page":"5183","article-title":"Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration","volume":"48","author":"Gottardis","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ijc.2910610417","article-title":"Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment","volume":"61","author":"Lykkesfeldt","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib23","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/endo.142.7.8259","article-title":"Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex)","volume":"142","author":"McClelland","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0960-0760(03)00139-0","article-title":"Studies on the development of resistance to the pure antiestrogen Faslodex\u2122 in three human breast cancer cell lines","volume":"85","author":"Sommer","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<1129::AID-IJC31>3.0.CO;2-X","article-title":"Resistance of human breast cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness","volume":"72","author":"Larsen","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjc.6690061","article-title":"Differential regulation of specific genes in MCF-7 and ICI182780-resistant cell line MCF-7\/182R-6","volume":"79","author":"Jensen","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib27","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1073\/pnas.89.9.4037","article-title":"Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover","volume":"89","author":"Dauvois","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0167-4781(02)00480-3","article-title":"Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells","volume":"1578","author":"Giamarchi","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/me.2002-0323","article-title":"The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor(ER)-\u03b1 and essential for the antiproliferative activity of ICI 182,780 in ER\u03b1-positive breast cancer cells","volume":"17","author":"Fan","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib30","first-page":"1","article-title":"Estrogens and antiestrogens. I. Physiology and mechanisms of action of estrogens and antiestrogens","volume":"135","author":"Oettel","year":"1999","journal-title":"Handbook Exp. Pharmacol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","article-title":"ER\u03b2: identification and characterization of a novel human estrogen receptor","volume":"392","author":"Mosselman","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors \u03b1 and \u03b2","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib33","first-page":"525","article-title":"Coexpression of estrogen receptor \u03b1 and \u03b2: poor prognostic factors in human breast cancer?","volume":"59","author":"Speirs","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib34","first-page":"2434","article-title":"Estrogen receptor \u03b2 protein in human breast cancer: correlation with clinical tumor parameters","volume":"63","author":"Fuqua","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1677\/erc.1.00822","article-title":"Prospective evaluation of estrogen receptor-\u03b2 in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients","volume":"11","author":"Cappelletti","year":"2004","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(04)01413-5","article-title":"Oestrogen receptor \u03b2: what it means for patients with breast cancer","volume":"5","author":"Speirs","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib37","first-page":"529","article-title":"Estrogen receptor-\u03b2 messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins","volume":"59","author":"Dotzlaw","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib38","first-page":"7490","article-title":"Low levels of estrogen receptor \u03b2 protein predict resistance to tamoxifen therapy in breast cancer","volume":"10","author":"Hopp","year":"2004","journal-title":"Clin. Chem. Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib39","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","article-title":"Differential ligand activation of estrogen receptors ER\u03b1 and ER\u03b2 at AP1 sites","volume":"277","author":"Paech","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01807363","article-title":"Biological differences among MCF-7 human breast cancer cell lines from different laboratories","volume":"9","author":"Osborne","year":"1987","journal-title":"Breast Cancer Res. Treatment"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib41","first-page":"119","article-title":"Effects of oestrogen on human breast cancer cells in culture","volume":"95B","author":"Darbre","year":"1989","journal-title":"Proc. R. Soc. Edinburgh"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0960-0760(01)00174-1","article-title":"Oestrogenic activity of parabens in MCF7 human breast cancer cells","volume":"80","author":"Byford","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib43","first-page":"349","article-title":"Effect of estradiol on human breast cancer cells in culture","volume":"43","author":"Darbre","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib44","series-title":"Steroid Hormones: A Practical Approach","author":"Green","year":"1987"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-2952(02)01187-5","article-title":"Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction: correlation with protein assays","volume":"64","author":"de Cremoux","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/path.1077","article-title":"Evaluation of seven oestrogen receptor \u03b2 antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue","volume":"197","author":"Skliris","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib47","series-title":"Final Technical Report T05025: Effect of Overexpression of ER Beta on the Molecular Action of Phytoestrogens","author":"Darbre","year":"2005"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib48","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1210\/endo.142.9.8395","article-title":"ER\u03b2 inhibits proliferation and invasion of breast cancer cells","volume":"142","author":"Lazennec","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-03-2446","article-title":"Estrogen receptor \u03b2 inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest","volume":"64","author":"Paruthiyil","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0308319100","article-title":"Estrogen receptor \u03b2 inhibits 17\u03b2-estradiol-stimulated proliferation of the breast cancer cell line T47D","volume":"101","author":"Strom","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib51","first-page":"5421","article-title":"Increased expression of estrogen receptor \u03b2 mRNA in tamoxifen-resistant breast cancer patients","volume":"59","author":"Speirs","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib52","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/en.2003-0567","article-title":"Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype","volume":"144","author":"Frasor","year":"2003","journal-title":"Endocrinol."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0092-8674(03)00934-6","article-title":"Estrogen receptor-\u03b1 directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter","volume":"115","author":"Metivier","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib54","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1074\/jbc.M311932200","article-title":"Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1677\/erc.0.0100517","article-title":"Estrogen receptor corepressors\u2014a role in human breast cancer?","volume":"10","author":"Dobrzycka","year":"2003","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib56","first-page":"4130","article-title":"Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling","volume":"60","author":"Badia","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(87)90121-8","article-title":"Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors","volume":"51","author":"Darbre","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s10495-005-2137-z","article-title":"Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells","author":"Kallio","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00001813-200409000-00008","article-title":"Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells","volume":"15","author":"Treeck","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/erc.1.00899","article-title":"Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines","volume":"12","author":"Vendrell","year":"2005","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.jsbmb.2005.11.005_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1677\/jme.0.0290175","article-title":"Development of cDNA microarray for expression profiling of estrogen-responsive genes","volume":"29","author":"Inoue","year":"2002","journal-title":"J. Mol. Endocr."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib62","first-page":"7158","article-title":"The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles","volume":"63","author":"Cunliffe","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2005.11.005_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/jme.1.01631","article-title":"Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells","volume":"34","author":"Gadal","year":"2005","journal-title":"J. Mol. Endocr."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600600032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600600032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:52:18Z","timestamp":1760734338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007600600032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S096007600600032X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.11.005","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in oestrogen receptor-\u03b1 and -\u03b2 during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}